Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASB6 antisense RNA 1 (ASB6-AS1) is a long non-coding antisense RNA gene located at the ASB6 locus. lncRNAs such as ASB6-AS1 regulate gene expression by hybridizing to their sense transcripts, influencing transcription, translation, and epigenetics through mechanisms such as DNA methylation and histone modification[1][5][6]. While many antisense RNAs modulate biological processes including cell differentiation and imprinting, there is currently no evidence that ASB6-AS1 is a direct therapeutic target, a disease biomarker, or is involved in a specific disease process. Its characterization as a regulatory RNA is supported by gene database entries and general lncRNA/antisense RNA literature, but detailed biological functions or disease roles for ASB6-AS1 specifically have not been reported. It is important to distinguish ASB6-AS1 (non-coding RNA gene) from ASB6 (protein coding, Ankyrin Repeat And SOCS Box Containing 6), which has roles in cancer and insulin signaling modulation[3][7]. There are no known drugs, biomarkers, or disease associations linked specifically to ASB6-AS1 in authoritative resources[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ASB6 antisense RNA 1 (ASB6-AS1).